<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Abbasi M</submitter><funding>Fundação para a Ciência e a Tecnologia</funding><pagination>40</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9233801</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>Drug design is an important area of study for pharmaceutical businesses. However, low efficacy, off-target delivery, time consumption, and high cost are challenges and can create barriers that impact this process. Deep Learning models are emerging as a promising solution to perform de novo drug design, i.e., to generate drug-like molecules tailored to specific needs. However, stereochemistry was not explicitly considered in the generated molecules, which is inevitable in targeted-oriented molecules. This paper proposes a framework based on Feedback Generative Adversarial Network (GAN) that includes optimization strategy by incorporating Encoder-Decoder, GAN, and Predictor deep models interconnected with a feedback loop. The Encoder-Decoder converts the string notations of molecules into la</pubmed_abstract><journal>Journal of cheminformatics</journal><pubmed_title>Designing optimized drug candidates with Generative Adversarial Network.</pubmed_title><pmcid>PMC9233801</pmcid><funding_grant_id>CENTRO-01-0145-FEDER-029266</funding_grant_id><pubmed_authors>Pereira TC</pubmed_authors><pubmed_authors>Brito RMM</pubmed_authors><pubmed_authors>Arrais JP</pubmed_authors><pubmed_authors>Santos BP</pubmed_authors><pubmed_authors>Abbasi M</pubmed_authors><pubmed_authors>Oliveira JL</pubmed_authors><pubmed_authors>Simoes CJV</pubmed_authors><pubmed_authors>Sofia R</pubmed_authors><pubmed_authors>Monteiro NRC</pubmed_authors><pubmed_authors>Ribeiro B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Designing optimized drug candidates with Generative Adversarial Network.</name><description>Drug design is an important area of study for pharmaceutical businesses. However, low efficacy, off-target delivery, time consumption, and high cost are challenges and can create barriers that impact this process. Deep Learning models are emerging as a promising solution to perform de novo drug design, i.e., to generate drug-like molecules tailored to specific needs. However, stereochemistry was not explicitly considered in the generated molecules, which is inevitable in targeted-oriented molecules. This paper proposes a framework based on Feedback Generative Adversarial Network (GAN) that includes optimization strategy by incorporating Encoder-Decoder, GAN, and Predictor deep models interconnected with a feedback loop. The Encoder-Decoder converts the string notations of molecules into la</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-26T02:47:26.584Z</modification><creation>2024-10-18T20:23:46.184Z</creation></dates><accession>S-EPMC9233801</accession><cross_references><pubmed>35754029</pubmed><doi>10.1186/s13321-022-00623-6</doi></cross_references></HashMap>